• Login
    View Item 
    •   SMARTech Home
    • Georgia Tech Theses and Dissertations
    • Georgia Tech Theses and Dissertations
    • View Item
    •   SMARTech Home
    • Georgia Tech Theses and Dissertations
    • Georgia Tech Theses and Dissertations
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Continuous manufacturing of beta-lactam antibiotics by enzymatic reactive crystallization

    Thumbnail
    View/Open
    MCDONALD-DISSERTATION-2020.pdf (8.018Mb)
    Date
    2020-10-12
    Author
    Mcdonald, Matthew Alexander
    Metadata
    Show full item record
    Abstract
    The enzymatic production of beta-lactam antibiotics can be simplified by integrating the synthesis and separation of the antibiotic within a single vessel. In situ crystallization during the synthesis of beta-lactam antibiotics improves yields by protecting the antibiotic, an intermediate in the enzyme catalyzed reaction pathway, from degradation by the enzyme. The design of a continuous synthesis, crystallization, and isolation (CSCI) process follows naturally because the reaction and crystallization kinetics are already coupled in the batch process. Rather than individually design and size several unit operations for use in series, a single unit that performs several operations at once was developed. The benefits of continuous reactive crystallization include simplified process control, improved environmental sustainability, and increased process performance. Enzyme catalysis decreases process mass intensity and increases reaction selectivity compared to chemical routes to beta-lactams. Use of process analytical technology (PAT) enables real time monitoring of critical process parameters (CPPs) to ensure production of pharmaceutical quality material. The kinetics of the enzyme reactions and antibiotic crystallization were determined in batch for ampicillin and cephalexin. A model of reactive crystallization was built and used to determine the optimal process configuration for continuous production of amoxicillin and cephalexin. Finally, implementation of the continuous process in the lab was begun. This process will enable more sustainable production of beta-lactam antibiotics with potential for on-demand production, especially important in light of recent drug shortages due to the 2020 SARS-CoV-2 pandemic.
    URI
    http://hdl.handle.net/1853/64110
    Collections
    • Georgia Tech Theses and Dissertations [23877]
    • School of Chemical and Biomolecular Engineering Theses and Dissertations [1516]

    Browse

    All of SMARTechCommunities & CollectionsDatesAuthorsTitlesSubjectsTypesThis CollectionDatesAuthorsTitlesSubjectsTypes

    My SMARTech

    Login

    Statistics

    View Usage StatisticsView Google Analytics Statistics
    facebook instagram twitter youtube
    • My Account
    • Contact us
    • Directory
    • Campus Map
    • Support/Give
    • Library Accessibility
      • About SMARTech
      • SMARTech Terms of Use
    Georgia Tech Library266 4th Street NW, Atlanta, GA 30332
    404.894.4500
    • Emergency Information
    • Legal and Privacy Information
    • Human Trafficking Notice
    • Accessibility
    • Accountability
    • Accreditation
    • Employment
    © 2020 Georgia Institute of Technology